Literature DB >> 16426191

Serum alkaline phosphatase activity in Scottish Terriers versus dogs of other breeds.

Derek D Nestor1, Kate M Holan, Cheri A Johnson, William Schall, John B Kaneene.   

Abstract

OBJECTIVE: To determine whether Scottish Terriers have higher serum alkaline phosphatase (ALP) activities and a higher prevalence of diseases commonly associated with high serum ALP activity than do dogs of other breeds.
DESIGN: Retrospective case-control study. ANIMALS: 85 Scottish Terriers and 340 age-matched control dogs that were not Scottish Terriers. PROCEDURE: Medical records were reviewed, and data for year of evaluation, age, sex, breed, serum ALP activity, and final diagnosis were recorded.
RESULTS: Scottish Terriers had a significantly higher mean serum ALP activity than did control dogs (1,520 U/L vs 306 U/L). Regardless of breed, dogs that had a disease commonly associated with high serum ALP activity had a significantly higher mean serum ALP activity than did dogs without such diseases (1,304 U/L vs 427 U/L). Scottish Terriers were 2.4 times as likely to have a disease commonly associated with high serum ALP activity than were control dogs, but Scottish Terriers with diseases commonly associated with high serum ALP activity had a significantly higher mean ALP activity than did control dogs with such diseases (2,073 U/L vs 909 U/L), and Scottish Terriers without such diseases had a significantly higher mean serum ALP activity than did control dogs without such diseases (1,349 U/L vs 228 U/L). CONCLUSIONS AND CLINICAL RELEVANCE: Results suggest that Scottish Terriers have higher serum ALP activities than do dogs of other breeds. Although Scottish Terriers also have a higher prevalence of diseases associated with high serum ALP activity, this alone did not explain the higher mean serum ALP activity in the breed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16426191     DOI: 10.2460/javma.228.2.222

Source DB:  PubMed          Journal:  J Am Vet Med Assoc        ISSN: 0003-1488            Impact factor:   1.936


  5 in total

1.  Use of serum biomarkers in staging of canine hepatic fibrosis.

Authors:  Maud Menard; Alexis Lecoindre; Jean-Luc Cadoré; Michèle Chevallier; Aurélie Pagnon; Juan Hernandez; Rodolpho Oliveira Leal; Marine Hugonnard; Véronique Miette; Marie Destro; Benoît Rannou; Ghita Benchekroun; Patrick Lecoindre
Journal:  J Vet Diagn Invest       Date:  2019-07-26       Impact factor: 1.279

Review 2.  Prognostic factors in canine appendicular osteosarcoma - a meta-analysis.

Authors:  Ilse Boerman; Gayathri T Selvarajah; Mirjam Nielen; Jolle Kirpensteijn
Journal:  BMC Vet Res       Date:  2012-05-15       Impact factor: 2.741

3.  Serum steroid profiling of hepatocellular carcinoma associated with hyperadrenocorticism in dogs: A preliminary study.

Authors:  Thandar Oo; Noboru Sasaki; Yoshinori Ikenaka; Takahiro Ichise; Noriyuki Nagata; Nozomu Yokoyama; Kazuyoshi Sasaoka; Keitaro Morishita; Kensuke Nakamura; Mitsuyoshi Takiguchi
Journal:  Front Vet Sci       Date:  2022-09-28

4.  Age-associated and breed-associated variations in haematological and biochemical variables in young labrador retriever and miniature schnauzer dogs.

Authors:  Thomas Brenten; Penelope J Morris; Carina Salt; Jens Raila; Barbara Kohn; Florian J Schweigert; Jürgen Zentek
Journal:  Vet Rec Open       Date:  2016-05-16

5.  Adrenocortical Challenge Response and Genomic Analyses in Scottish Terriers With Increased Alkaline Phosphate Activity.

Authors:  Kurt L Zimmerman; David L Panciera; Ina Hoeschele; W Edward Monroe; Stephanie Michelle Todd; Stephen R Werre; Tanya LeRoith; Kellie Fecteau; Bathilda B Lake
Journal:  Front Vet Sci       Date:  2018-10-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.